TrialBreast cancer research and treatment2017

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer.

J S Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.